Vanguard Group Inc Spring Works Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SWTX
# of Institutions
234Shares Held
67.7MCall Options Held
546KPut Options Held
29.4K-
Black Rock Inc. New York, NY5.44MShares$205 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.11MShares$155 Million0.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.48MShares$131 Million5.66% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$129 Million8.76% of portfolio
-
Marshall Wace, LLP London, X02.97MShares$112 Million0.23% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.35B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...